Heritage Cannabis Holdings Corp appoints Umar Syed as president medical products role

Heritage Cannabis Holdings Corp (CSE:CANN) (OTCQX:HERTF) (FRA:2UE) announced Wednesday that it has named medical cannabis executive Umar Syed as its new president of US and international medical products. 

Syed was CEO of Opticann Inc, a cannabinoid company that Heritage acquired earlier this month. Before that, he served as senior vice president of corporate development at MedReleaf Corp, a medical cannabis company that was bought by Aurora Cannabis Inc (TSE:ACB) (NYSE:ACB) (FRA:21P1) for $3.2 billion in 2018. 

All told, Syed has more than 20 years of leadership experience in the pharmaceutical and medical cannabis industries, including handling international corporate strategy for Pharmascience Canada.

READ: Heritage Cannabis subsidiary receives sales license from Health Canada

He was part of the founding management team of the first medical cannabis product development company in Canada in 2004. Cynapsus Therapeutics developed filmstrip drug delivery technology for Parkinsons’ Disease before it was sold to Sunovion Pharmaceuticals of Japan for $842 million in 2016.

“Umar is well-positioned to drive the advancement of our US mass-market presence and increase our participation in the rapidly growing multi-billion dollar US and international cannabis and hemp markets,” CEO Clint Sharples said in a statement. “He is an experienced executive with a successful track record in medical businesses, building high-performance teams, and with his strong cannabis industry experience, he is an important addition to the Heritage team.”

Heritage is a vertically integrated cannabis provider that operates through its subsidiaries and provides them with resources to advance their product ranges to compete domestically in the Canadian market and internationally.

Contact Andrew Kessel at [email protected]

Follow him on Twitter @andrew_kessel

Story by ProactiveInvestors